Reduced high-density lipoprotein cholesterol in patients receiving rosiglitazone and fenofibrate

Am J Med. 2008 Oct;121(10):e3-4. doi: 10.1016/j.amjmed.2008.06.019.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Cholesterol, HDL / blood*
  • Drug Therapy, Combination
  • Female
  • Fenofibrate / adverse effects*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypolipidemic Agents / adverse effects*
  • Male
  • Middle Aged
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*

Substances

  • Cholesterol, HDL
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Fenofibrate